Business Context and Reporting Period
Company: Natural Alternatives International, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2001 (Third Quarter of Fiscal Year 2001)
Business Overview: The Company manufactures and distributes dietary supplements, vitamins, and nutritional products. Operations include facilities in San Marcos, California, and Lugano, Switzerland. The Company is actively pursuing a cost containment program and diversifying sales channels through direct-to-consumer initiatives (Dr. Cherry brand) and international expansion.
Key Financial Metrics
| Metric (in thousands) | Q3 2001 | Q3 2000 | 9 Months 2001 | 9 Months 2000 |
|---|---|---|---|---|
| Net Sales | $10,341 | $9,538 | $31,804 | $36,866 |
| Gross Profit | $2,290 | $596 | $7,146 | $2,954 |
| Gross Margin % | 22% | 6% | 22% | 8% |
| Net Earnings (Loss) | ($234) | ($1,763) | $414 | ($4,087) |
| EPS (Basic/Diluted) | ($0.04) | ($0.31) | $0.07 | ($0.71) |
| Cash from Operations (9mo) | $3,645 (2001) vs $79 (2000) | |||
| Total Debt (Outstanding) | $5.4 million (as of Mar 31, 2001) | |||
| Cash & Equivalents | $485 (as of Mar 31, 2001) |
Material Changes vs. Prior Period
- Revenue Trends: Q3 2001 sales increased 8% year-over-year, driven by direct-to-consumer growth ($1.7M vs $66k prior year). However, nine-month sales decreased 14% due to the loss of two major customers (NuSkin Enterprises and Bally Total Fitness), which accounted for $8.0M in sales in the prior period.
- Profitability Improvement: The Company returned to profitability for the nine-month period ($414k net earnings) compared to a $4.1M loss in the prior year. This was achieved despite lower sales, primarily due to a significant improvement in gross margins (22% vs 8%) and cost containment measures.
- Margin Drivers: Gross margin expansion was driven by bringing packaging operations in-house (reducing outside packaging costs from 13% to 2% of sales) and a reduction in direct/indirect manufacturing expenses.
- Expense Increases: Selling, general, and administrative (SG&A) expenses increased in Q3 due to litigation costs ($236k), bad debt provisions ($240k), and advertising for new product lines. Nine-month SG&A decreased overall due to the cost containment program and the absence of non-recurring start-up costs from the prior year.
- Debt Reduction: Total consolidated debt decreased by approximately $3.0 million to $5.4 million, utilizing strong operating cash flows to pay down lines of credit.
Guidance, Outlook, Risks, and Unusual Items
- Joint Venture Default: The Company's joint venture partner, FitnessAge, defaulted on a restructured loan. The Company has taken full ownership and possession of the collateral, including Custom Nutrition LLC and proprietary software licenses. The Company is evaluating options to commercialize these assets or restructure the venture.
- Legal Proceedings:
- Spencer Lawsuit: The Company is defending a lawsuit filed by a former executive alleging damages in excess of $6 million. Management believes the claims are without merit but anticipates significant ongoing legal expenses.
- Antitrust Settlement: The Company received approximately $299,000 in settlements from an antitrust lawsuit against vitamin manufacturers during the nine-month period.
- Covenant Compliance Risk: While currently in compliance with financial covenants (minimum tangible net worth, leverage ratios), management does not anticipate compliance with these requirements at the end of the fiscal year (June 30, 2001). Failure to comply could result in a default and acceleration of debt.
- Customer Concentration: The Company remains highly dependent on a limited number of customers. Three major customers accounted for approximately 72% of net sales for the nine months ended March 31, 2001.
- Outlook: Management is committed to restoring net earnings through cost control and diversification but notes that future profitability is not assured due to market competition and the need to maintain expenses consistent with current operating levels.
Investor Verification Checklist
- Covenant Compliance: Verify the Company's ability to meet financial covenants by June 30, 2001, and the potential impact of a default on liquidity.
- Customer Concentration: Assess the stability of the top three customers, which represent the majority of revenue, and the risk of further attrition.
- Joint Venture Asset Value: Evaluate the commercial viability and valuation of the assets acquired from the FitnessAge default (Custom Nutrition LLC and software licenses).
- Legal Exposure: Monitor the status and potential cost of the Spencer lawsuit and the resolution of the antitrust litigation.
- Direct-to-Consumer Growth: Confirm the sustainability of the growth in the Dr. Cherry direct-to-consumer channel as an offset to wholesale customer losses.